Division of Nephrology, Department of Medicine, Duke University and Durham, VA Medical Centers, Durham, NC 27710, USA.
Department of Cell and Neurobiology, University of Southern California, Los Angeles, CA 90089, USA.
Cell Metab. 2011 Apr 6;13(4):469-475. doi: 10.1016/j.cmet.2011.03.001.
Hypertension affects more than 1.5 billion people worldwide but the precise cause of elevated blood pressure (BP) cannot be determined in most affected individuals. Nonetheless, blockade of the renin-angiotensin system (RAS) lowers BP in the majority of patients with hypertension. Despite its apparent role in hypertension pathogenesis, the key cellular targets of the RAS that control BP have not been clearly identified. Here we demonstrate that RAS actions in the epithelium of the proximal tubule have a critical and nonredundant role in determining the level of BP. Abrogation of AT(1) angiotensin receptor signaling in the proximal tubule alone is sufficient to lower BP, despite intact vascular responses. Elimination of this pathway reduces proximal fluid reabsorption and alters expression of key sodium transporters, modifying pressure-natriuresis and providing substantial protection against hypertension. Thus, effectively targeting epithelial functions of the proximal tubule of the kidney should be a useful therapeutic strategy in hypertension.
高血压影响着全球超过 15 亿人,但大多数受影响的个体无法确定导致血压升高的确切原因。尽管如此,肾素-血管紧张素系统 (RAS) 的阻断可降低大多数高血压患者的血压。尽管 RAS 在高血压发病机制中显然具有作用,但控制血压的 RAS 的关键细胞靶标尚未明确确定。在这里,我们证明了 RAS 在近端肾小管上皮细胞中的作用在确定血压水平方面具有关键且不可替代的作用。单独阻断近端肾小管中的 AT(1)血管紧张素受体信号足以降低血压,尽管血管反应完整。消除该途径可减少近端液的重吸收,并改变关键钠转运体的表达,改变压力-利尿作用,并为高血压提供实质性保护。因此,靶向肾脏近端小管的上皮功能可能是高血压的一种有用的治疗策略。